Allovir, Inc. Business Finance Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Kalaris Therapeutics, Inc. 2020 Stock Option and Grant Plan (as Amended)
Stock Agreements
Allovir, Inc.
Biotechnology
MA
2025
AlloVir, Inc. Underwriting Agreement for 20,000,000 Shares of Common Stock with J.P. Morgan, Morgan Stanley, and BofA Securities
Underwriting Agreements
Allovir, Inc.
Biotechnology
NY
2023
Securities Purchase Agreement between AlloVir, Inc. and Purchasers dated July 26, 2022
Purchase Agreements
Allovir, Inc.
Biotechnology
NY
2022
Description of AlloVir, Inc. Capital Stock and Registration Rights under Section 12 of the Exchange Act
Registration Rights Agreements
Allovir, Inc.
Biotechnology
DE
2021
Redeemable Preferred Stock Redemption Agreement between Viracyte, Inc. and Shareholders
Purchase Agreements
Allovir, Inc.
Biotechnology
DE
2020
AlloVir, Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Allovir, Inc.
Biotechnology
MA
2020
AlloVir, Inc. 2020 Stock Option and Grant Plan
Stock Agreements
Allovir, Inc.
Biotechnology
MA
2020
Allovir, Inc. Common Stock Certificate Issued to Alexander David Sample
Stock Agreements
Allovir, Inc.
Biotechnology
2020
AlloVir, Inc. Underwriting Agreement with Morgan Stanley, J.P. Morgan, and SVB Leerink (July 2020)
Underwriting Agreements
Allovir, Inc.
Biotechnology
NY
2020
ViraCyte, Inc. 2018 Equity Incentive Plan
Equity Distribution Agreements
Allovir, Inc.
Biotechnology
TX
2020
Amended and Restated Investors' Rights Agreement among ViraCyte, Inc. and Investors
Investor Rights Agreements
Allovir, Inc.
Biotechnology
DE
2020